RxDoctor Payments Data

Jonathan Silver, MD

Clinical Cardiac Electrophysiology · Burlington, MANPI 1033153176

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $62,406 of the $101,536 with a category attached, or 61.5%. 10 manufacturers reported payments, led by Abbott at 51.0% of the total.

$101,536in general payments, 2019–2025

Across 269 payments — averaging $377.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$52K
  • Boston Scientific$29K
  • Medtronic$10K
  • Atricure, Inc.$7K
  • Altathera Pharmaceuticals LLC$1K
  • Biosense Webster, Inc.$1K
  • plus $1K from 4 others
$24,986in research payments, 2019–2025

Across 59 payments — averaging $423.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$22K
  • Atricure, Inc.$3K

What the payments were for

  • Consulting fees$19,67519%
  • Speaking & faculty fees$62,40661%
  • Travel & lodging$9,95510%
  • Food & beverage$9,4999%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$101,536 in reported general payments places this provider in the 80th percentile of 106 clinical cardiac electrophysiology providers in Massachusetts.

See all clinical cardiac electrophysiology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$281,129
Medicare patients
2,983
Services billed
4,141

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban42$31,570
XareltoRivaroxaban16$18,002
Flecainide Acetate27$1,530
Amiodarone Hcl29$551
Diltiazem 24hr Er (Cd)Diltiazem Hcl16$323
Metoprolol Succinate13$237
Warfarin Sodium14$162

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Burlington

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →